References:
1 van der Hooft CS, Heeringa J, van Herpen G, Kors JA, Kingma JH, Stricker BH: Drug-induced atrial fibrillation. J AM COLL CARDIOL 2004; 44:2117-2124.
2 Kaakeh Y, Overholser BR, Lopshire JC, Tisdale JE: Drug-Induced Atrial Fibrillation. DRUGS 2012; 72:1617-1630.
3 Lei M, Wu L, Terrar DA, Huang CLH: Modernized Classification of Cardiac Antiarrhythmic Drugs. CIRCULATION 2018; 138:1879-1896.
4 Cappato R, Castelvecchio S, Ricci C, Bianco E, Vitali-Serdoz L, Gnecchi-Ruscone T, Pittalis M, De Ambroggi L, Baruscotti M, Gaeta M, Furlanello F, Di Francesco D, Lupo PP: Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation. J AM COLL CARDIOL 2012; 60:1323-1329.
5 Chow SL, Page RN, Depre C: Role of ivabradine and heart rate lowering in chronic heart failure: guideline update. Expert Rev Cardiovasc Ther 2018; 16:515-526.
6 Dvir D, Battler A: Conventional and novel drug therapeutics to relief myocardial ischemia. Cardiovasc Drugs Ther 2010; 24:319-323.
7 Wang J, Yang YM, Li Y, Zhu J, Lian H, Shao XH, Zhang H, Fu YC, Zhang LF: Long-term treatment with ivabradine in transgenic atrial fibrillation mice counteracts hyperpolarization-activated cyclic nucleotide gated channel overexpression. J Cardiovasc Electrophysiol 2019; 30:242-252.
8 Burashnikov A, Antzelevitch C: Reinduction of atrial fibrillation immediately after termination of the arrhythmia is mediated by late phase 3 early afterdepolarization-induced triggered activity. CIRCULATION 2003; 107:2355-2360.
9 Tanboga IH, Topcu S, Aksakal E, Gulcu O, Aksakal E, Aksu U, Oduncu V, Ulusoy FR, Sevimli S, Kaymaz C: The Risk of Atrial Fibrillation With Ivabradine Treatment: A Meta-analysis With Trial Sequential Analysis of More Than 40000 Patients. CLIN CARDIOL 2016; 39:615-620.
10 Wu L, Rajamani S, Shryock JC, Li H, Ruskin J, Antzelevitch C, Belardinelli L: Augmentation of late sodium current unmasks the proarrhythmic effects of amiodarone. CARDIOVASC RES 2008; 77:481-488.
11 Zhang Q, Ma JH, Li H, Wei XH, Zheng J, Li G, Wang CY, Wu Y, He QH, Wu L: Increase in CO2 levels by upregulating late sodium current is proarrhythmic in the heart. HEART RHYTHM 2019; 16:1098-1106.
12 Picht E, Zima AV, Blatter LA, Bers DM: SparkMaster: automated calcium spark analysis with ImageJ. Am J Physiol Cell Physiol 2007; 293:C1073-C1081.
13 Zhang Q, Ma J, Li H, Wei X, Zheng J, Li G, Wang C, Wu Y, He Q, Wu L: Increase in CO2 levels by upregulating late sodium current is proarrhythmic in the heart. HEART RHYTHM 2019; 16:1098-1106.
14 Sheldon RS, Grubb BP, Olshansky B, Shen W, Calkins H, Brignole M, Raj SR, Krahn AD, Morillo CA, Stewart JM, Sutton R, Sandroni P, Friday KJ, Hachul DT, Cohen MI, Lau DH, Mayuga KA, Moak JP, Sandhu RK, Kanjwal K: 2015 Heart Rhythm Society Expert Consensus Statement on the Diagnosis and Treatment of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia, and Vasovagal Syncope. HEART RHYTHM 2015; 12:e41-e63.
15 Ceconi C, Cargnoni A, Francolini G, Parinello G, Ferrari R: Heart rate reduction with ivabradine improves energy metabolism and mechanical function of isolated ischaemic rabbit heart. CARDIOVASC RES 2009; 84:72-82.
16 Chu Y, Yang Q, Ren L, Yu S, Liu Z, Chen Y, Wei X, Huang S, Song L, Zhang P, Ma J, Wu L: Late Sodium Current in Atrial Cardiomyocytes Contributes to the Induced and Spontaneous Atrial Fibrillation in Rabbit Hearts. J Cardiovasc Pharmacol 2020; 76:437-444.
17 Suenari K, Cheng CC, Chen YC, Lin YK, Nakano Y, Kihara Y, Chen SA, Chen YJ: Effects of ivabradine on the pulmonary vein electrical activity and modulation of pacemaker currents and calcium homeostasis. J Cardiovasc Electrophysiol 2012; 23:200-206.
18 DiFrancesco D, Camm JA: Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease. DRUGS 2004; 64:1757-1765.
19 Wu L, Ma J, Li H, Wang C, Grandi E, Zhang P, Luo A, Bers DM, Shryock JC, Belardinelli L: Late sodium current contributes to the reverse rate-dependent effect of IKr inhibition on ventricular repolarization. CIRCULATION 2011; 123:1713-1720.
20 Martin RI, Pogoryelova O, Koref MS, Bourke JP, Teare MD, Keavney BD: Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials. HEART 2014; 100:1506-1510.
21 Wu L, Rajamani S, Li H, January CT, Shryock JC, Belardinelli L: Reduction of repolarization reserve unmasks the proarrhythmic role of endogenous late Na(+) current in the heart. Am J Physiol Heart Circ Physiol 2009; 297:H1048-H1057.
22 Kleinbongard P, Gedik N, Witting P, Freedman B, Klocker N, Heusch G: Pleiotropic, heart rate-independent cardioprotection by ivabradine. Br J Pharmacol 2015; 172:4380-4390.
23 van der Heyden MA, Jespersen T: Pharmacological exploration of the resting membrane potential reserve: Impact on atrial fibrillation. EUR J PHARMACOL 2016; 771:56-64.
24 Voigt N, Li N, Wang Q, Wang W, Trafford AW, Abu-Taha I, Sun Q, Wieland T, Ravens U, Nattel S, Wehrens XH, Dobrev D: Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation. CIRCULATION 2012; 125:2059-2070.
25 Voigt N, Heijman J, Wang Q, Chiang DY, Li N, Karck M, Wehrens X, Nattel S, Dobrev D: Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation. CIRCULATION 2014; 129:145-156.
26 Cheng H, Lederer WJ, Cannell MB: Calcium sparks: elementary events underlying excitation-contraction coupling in heart muscle. SCIENCE 1993; 262:740-744.
27 Zima AV, Bovo E, Bers DM, Blatter LA: Ca(2)+ spark-dependent and -independent sarcoplasmic reticulum Ca(2)+ leak in normal and failing rabbit ventricular myocytes. J Physiol 2010; 588:4743-4757.
28 Satoh H, Blatter LA, Bers DM: Effects of [Ca2+]i, SR Ca2+ load, and rest on Ca2+ spark frequency in ventricular myocytes. Am J Physiol 1997; 272:H657-H668.
29 Hove-Madsen L, Llach A, Bayes-Genis A, Roura S, Rodriguez FE, Aris A, Cinca J: Atrial fibrillation is associated with increased spontaneous calcium release from the sarcoplasmic reticulum in human atrial myocytes. CIRCULATION 2004; 110:1358-1363.
30 Neef S, Dybkova N, Sossalla S, Ort KR, Fluschnik N, Neumann K, Seipelt R, Schondube FA, Hasenfuss G, Maier LS: CaMKII-dependent diastolic SR Ca2+ leak and elevated diastolic Ca2+ levels in right atrial myocardium of patients with atrial fibrillation. CIRC RES 2010; 106:1134-1144.
31 Gyorke I, Gyorke S: Regulation of the cardiac ryanodine receptor channel by luminal Ca2+ involves luminal Ca2+ sensing sites. BIOPHYS J 1998; 75:2801-2810.
32 Wier WG, Cannell MB, Berlin JR, Marban E, Lederer WJ: Cellular and subcellular heterogeneity of [Ca2+]i in single heart cells revealed by fura-2. SCIENCE 1987; 235:325-328.
33 Tamargo J, Caballero R, Delpon E: Drug-induced atrial fibrillation. EXPERT OPIN DRUG SAF 2012; 11:615-634.